These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6087408)

  • 1. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 3. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Hammerschmidt W; Sugden B
    Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV expression in human non-lymphoid hematopoietic cell lines.
    Rocchi G; Ragona G; Revoltella RP
    Prog Med Virol; 1984; 30():129-38. PubMed ID: 6087409
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural organization of the Epstein-Barr virus genome].
    D'iachenko AG
    Eksp Onkol; 1984; 6(4):3-10. PubMed ID: 6209094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
    Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
    Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology and chemistry of Epstein-Barr virus.
    Kieff E; Dambaugh T; Heller M; King W; Cheung A; van Santen V; Hummel M; Beisel C; Fennewald S; Hennessy K; Heineman T
    J Infect Dis; 1982 Oct; 146(4):506-17. PubMed ID: 6288806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process of immortalization by Epstein-Barr virus and oncogenic conversion of the immortalized cells.
    Nonoyama M; Tanaka A; Ozaki H
    AIDS Res; 1986 Dec; 2 Suppl 1():S103-8. PubMed ID: 2881553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency.
    Rogers RP; Strominger JL; Speck SH
    Adv Cancer Res; 1992; 58():1-26. PubMed ID: 1312289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency].
    Takada K
    Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation.
    Gratama JW; Oosterveer MA; Lepoutre J; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Klein G; Ernberg I
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3097-8. PubMed ID: 2539687
    [No Abstract]   [Full Text] [Related]  

  • 18. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of Epstein-Barr virus.
    Ooka T
    Biomed Pharmacother; 1985; 39(2):59-66. PubMed ID: 2990591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation induced by Epstein-Barr virus and the role of the nuclear antigen.
    Klein G; Luka J; Zeuthen J
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():253-61. PubMed ID: 6253139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.